NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=178826&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE:INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=178825&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Preclinical Results Demonstrate Complete Response and Tumor Regression in ACC PDX Models Pin Therapeutics, a clinical-stage biotechnology company specializing in targeted protein degradation, announced on November 20 that it has administered the first dose of its CK1a-selective degrader PIN-5018 in a Phase 1 clinical trial. The first patient enrolled has adenoid cystic carcinoma (ACC), a

ASSAABLOY has acquired International Door Products (“IDP”), a US manufacturer of standard and custom fire-rated steel door frames. “I am very pleased to welcome IDP to ASSA ABLOY. This acquisition delivers on our strategy to strengthen our position in mature markets through adding complementary products and solutions to our core business,” says Nico Delvaux, President

TheSchall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstSynopsys, Inc. (“Synopsys” or “the Company”) (NASDAQ: SNPS)forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's securities between

NEW YORK, NY / ACCESS Newswire / November 24, 2025 / If you suffered a loss on your Molina Healthcare, Inc. (NYSE:MOH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/molina-healthcare-inc-lawsuit-submission-form?prid=178824&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

The DJS Law Group reminds investors of a class action lawsuit against Synopsys, Inc. (“Synopsys ” or “the Company”) (NASDAQ: SNPS ) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of SNPS during the class

Powering NATO's digital modernization and protecting alliance data with Google Distributed Cloud air-gapped Google Cloud today announced a significant, multi-million-dollar contract with the NATO Communication and Information Agency (NCIA) to deliver highly secure, sovereign cloud capabilities. This strategic partnership is a major step in bolstering NATO's digital infrastructure, strengthening its data governance, and enabling it

Organizations should prepare for a surge in ransomware attacks during holidays, weekends, and major corporate events, when cybersecurity staffing is its weakest. Semperis, a leading provider of AI-powered identity security and cyber resilience, today released results from a global ransomware study underscoring that the majority of ransomware attacks continue to occur on holidays and weekends,

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstInspire Medical Systems, Inc. (“Inspire” or “the Company”) (NYSE: INSP) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased